VOLT vs CCRN

For growth investors, Volt Information Sciences, Inc.

(VOLT) is the stronger pick with 7. 7% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Volt Information Sciences, Inc. (VOLT) offers the better valuation at 680. 9x trailing P/E, making it the more compelling value choice. Analysts rate Cross Country Healthcare, Inc. (CCRN) a "Hold" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Volt Information Sciences, Inc.

(VOLT) delivered a total return of +956. 8%, compared to -37. 2% for Cross Country Healthcare, Inc. (CCRN). Over 10 years, the gap is even starker: VOLT returned +1198% versus CCRN's -28. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 78β versus Volt Information Sciences, Inc. 's 0. 98β — meaning VOLT is approximately 26% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 3% for Volt Information Sciences, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Volt Information Sciences, Inc.

(VOLT) is pulling ahead at 7. 7% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: Volt Information Sciences, Inc. grew EPS 103. 9% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Over a 3-year CAGR, VOLT leads at -5. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Volt Information Sciences, Inc.

(VOLT) is the more profitable company, earning 0. 2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 0. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VOLT leads at 0. 5% versus -0. 3% for CCRN. At the gross margin level — before operating expenses — CCRN leads at 18. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Volt Information Sciences, Inc.

(VOLT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1198% 10Y return). Both have compounded well over 10 years (VOLT: +1198%, CCRN: -28. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VOLT (Industrials) and CCRN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.